SCORE

23

TNXP: Tonix Pharmaceuticals Holding Corp. is a Sell


The current rating for TNXP is 23, which is 117% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.